Establishing the Medication Safety Research Network of Indiana (Rx-SafeNet): Perspectives of Community Pharmacy Employees by Seel, Lindsey V. et al.
Volume 3 | Number 2 Article 79
2012
Establishing the Medication Safety Research
Network of Indiana (Rx-SafeNet): Perspectives of
Community Pharmacy Employees
Lindsey V. Seel
Kyle E. Hultgren
Margie E. Snyder
Follow this and additional works at: http://pubs.lib.umn.edu/innovations
INNOVATIONS in pharmacy is published by the University of Minnesota Libraries Publishing.
Recommended Citation
Seel LV, Hultgren KE, Snyder ME. Establishing the Medication Safety Research Network of Indiana (Rx-SafeNet): Perspectives of
Community Pharmacy Employees. Inov Pharm. 2012;3(2): Article 79. http://pubs.lib.umn.edu/innovations/vol3/iss2/6
Original Research PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                       2012, Vol. 3, No. 2, Article 79                           INNOVATIONS in pharmacy   1 
 
Establishing the Medication Safety Research Network of Indiana (Rx-SafeNet): Perspectives 
of Community Pharmacy Employees 
Lindsey V. Seel, B.A., Pharm.D. Candidate 2013
1
; Kyle E. Hultgren, Pharm.D.
1,2
; and Margie E. Snyder, Pharm.D., M.P.H.
1,2
 
1
 Purdue University College of Pharmacy, West Lafayette, IN 
2
 Purdue University College of Pharmacy Center for Medication Safety Advancement, Indianapolis, IN 
 
Financial Disclosure Statement:  Dr. Snyder’s effort was supported in part by KL2RR025760 (A. Shekhar, PI).  The Center for 
Medication Safety Advancement and Rx-SafeNet were founded with funding from a Lilly Endowment Grant. 
Conflict of Interest Disclosure Statement:  The authors declare no conflicts of interests or financial interests in any product or 
service mentioned in this article, including grants, employments, gifts, stock, holdings, or honoraria. 
Acknowledgments:  The authors would like to thank all of the individuals that assisted with reviewing and pilot-testing the survey 
questions, along with Mark Sharp for technical assistance in creating the online survey. We would also like to thank Dr. Mick Murray 
for advice on statistical analyses, Drs. Karen Hudmon and Caity Frail and Ms. Brenda Hudson for their critical reviews of earlier drafts 
of this paper, and Dr. Matthew Hoch for his assistance in preparing this manuscript. 
Previous Presentations:  Poster presented at the 2010 American College of Clinical Pharmacy Annual Meeting in Austin, TX. 
Keywords:  practice-based research networks, research, pharmacy practice, medication safety, community pharmacy 
 
Abstract 
The objective of this cross-sectional survey was to determine community pharmacy employee research project priorities and assess 
interest levels, barriers, and facilitators to joining a new community pharmacy practice-based research network (PBRN) and use this 
information in subsequent PBRN development.  One hundred forty pharmacists and 40 support staff responded.  The majority (72%) 
of respondents were somewhat interested or needed more information to determine their level of interest in joining a PBRN; 15% 
were very interested.  While all research topics were regarded as important, dispensing errors were rated as the most important.  
Time constraints were considered the greatest barrier to participation.  Greater knowledge of medication safety, enrichment of 
patient care, and improved patient and provider relationships were considered important reasons for joining a PBRN.  Responses 
indicated favorable interest levels and project support from potential network members, though education and awareness 
campaigns are needed to enhance community pharmacy employee understanding of and involvement in research and PBRNs, 
specifically the Medication Safety Research Network of Indiana (Rx-SafeNet), a new network administered by the Purdue University 
College of Pharmacy.  While the generalizability of survey results is limited, they were useful in determining policies and procedures 
of the new network.  Surveying all employees involved in the future PBRN during the network development process is a unique 
approach to developing these types of networks in the U.S.  Understanding support staff perspectives is important considering the 
critical role they play in project implementation and operations.  Emerging PBRNs from any discipline may benefit from considering 
adding this step to their development. 
 
 
Introduction 
In pursuit of expanding medication safety research and 
practice models that enhance safety, the Purdue University 
College of Pharmacy launched the Center for Medication 
Safety Advancement (CMSA)
1
 in March 2010.  One specific 
area of focus for CMSA is the advancement of community 
pharmacy through the development of innovative practice 
models.  To facilitate this, CMSA serves as the administrative 
unit for a new community pharmacy practice-based research  
network (PBRN), the Medication Safety Research Network of  
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Indiana (Rx-SafeNet).
2
  Rx-SafeNet’s mission is to “improve 
medication safety and advance community pharmacy 
practice in Indiana through the conduct and dissemination of 
collaborative, patient-centered, practice-based research.” 
 
To enhance the development of Rx-SafeNet, we examined 
network planning strategies from published literature
3-7
 and 
used this existing literature to develop a survey administered 
to future Rx-SafeNet participants (i.e., community pharmacy 
employees including pharmacists, technicians, students etc.).   
 
The purpose of the survey was primarily to explore employee 
perceptions and experiences about research, network 
participation, and project topics, and use this information in 
subsequent network planning.)It was also the hope of the 
study authors to help create network “ownership” among 
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community pharmacy stakeholders in the state by inviting 
survey respondents to vote on the official name of the new 
PBRN.  It was never the intention of survey results to truly 
characterize the opinions of all Indiana pharmacy employees, 
but instead, to provide insight and direction in the unique 
development of a statewide community pharmacy PBRN.  
 
In designing the survey, we specifically considered the work 
of Bakken et al. and others
3-5
 in developing response options 
for perceived barriers and facilitators.  Our approach to the 
timing of the survey—shortly before member recruitment—is 
similar to the approach used by Gibson et al. in starting a new 
physician PBRN in New York
8
 and to Carr et al. in considering 
interest in a community pharmacy network in Kentucky.
9
  
However, in both of those cases only the clinician (i.e., 
physician or pharmacist) was surveyed.  Like us, Seston et al. 
described the development of a community pharmacy PBRN 
and surveyed all pharmacy employees throughout its 
development.
4
  We believe this approach is desirable as all 
employees in a pharmacy may contribute to PBRN projects 
and the success of their implementation.  Furthermore, 
understanding any differences in perspectives between 
pharmacists and other staff on PBRN issues may highlight 
opportunities to follow up specifically with one group or 
another to meet their needs.  However, the network they 
describe is located in the U.K., where pharmacy regulations 
and practice norms may differ.  To our knowledge, our 
developmental approach describes the first survey in U.S. 
PBRN literature to consider the perspectives of all types of 
employees of a network pharmacy and use these data to 
influence policies and procedures of the new PBRN.  This 
paper will describe the methods and results of the survey, 
and show how such an approach can influence a network’s 
development as well as be predictive of the needs and 
interests of future members.  In this way, the following 
information can be seen as one, innovative, step in the larger 
establishment of Rx-SafeNet (see Snyder, et al. for additional 
details regarding the network’s formation)
10
 which can be 
drawn upon to provide a unique developmental model for a 
variety of PBRNs. 
 
Methods 
All community pharmacists and staff aged 18 years or older 
working in Indiana during March-May 2010 were eligible for 
survey participation.  Membership in Rx-SafeNet occurs at the 
pharmacy level.  However, the decision to join and success of 
resulting projects may be influenced by all staff members.  
Therefore, we set out to capture opinions from any willing 
community pharmacy employee. 
 
 
 
Survey Instrument Development 
As described above, items were written to encompass issues 
previously identified in the literature as significant for the 
development of PBRNs
3-5
 with an emphasis on issues relevant 
to the formation of Rx-SafeNet in particular. 
 
The first section of items consisted of closed-ended and 
partially closed-ended questions that obtained basic 
information about the respondent’s position in the pharmacy 
and the pharmacy itself (e.g., pharmacy type as chain, 
independent, etc.).  The second domain of items, primarily 
closed-ended questions, characterized respondents’ previous 
training and experience pertaining to research and PBRNs.  
The third group asked respondents to rate the level of 
importance (on a scale from 1= not at all important to 10= 
very important) of medication safety research topics, along 
with reasons to potentially participate or not participate in 
the PBRN, and to indicate their current level of interest in the 
PBRN.  This section also included open-ended items for 
respondents to add any additional topics or reasons they 
could identify for participating or not.  Additionally, this 
section included items asking respondents to select the most 
interesting topic and most important potential reasons for 
either participating or not.  Also in this section, one item 
invited participants to vote on the official name of the new 
PBRN.  This approach was taken to foster ownership among 
Indiana community pharmacy employees, and subsequently, 
the inaugural network members.  The final group of items 
assessed basic demographic information. 
 
A draft was reviewed by the Purdue College of Pharmacy 
Ambulatory Care Research Committee.  Furthermore, limited 
pilot testing was performed with colleagues (both a 
pharmacist and two technicians) in community pharmacy to 
assess questionnaire content.  Finally, brief pilots of the 
online survey were performed to ensure functionality.  The 
final web-based survey (Appendices A and B; only difference 
was minor differences in demographics requested from 
pharmacists versus staff) was administered using the 
Qualtrics™ software program. 
 
Recruitment Strategies 
All community pharmacies in Indiana (n= 1125) were sent an 
initial mailing, addressed to the pharmacist-in-charge as 
identified by the list obtained from the Indiana Professional 
Licensing Agency, consisting of a cover letter (which included 
a description of PBRNs and examples), a research participant 
information sheet, and five small cards with the survey URL 
printed on them.  The cards were to be distributed to other 
pharmacy employees.  Three follow-up mailings occurred at 
approximately 1-week intervals. 
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Additionally, information about the study (and survey URL) 
was sent to members of the Medication Safety Partnership of 
Indiana (MSPI), a group of approximately 20 Indiana 
pharmacy stakeholders interested in medication safety.  MSPI 
members were asked to share the study information and URL 
with colleagues in community pharmacy in order to 
encourage study participation. 
The study protocol was approved by the Purdue University 
Institutional Review Board.  Participants received no 
compensation and indicated their eligibility and consent by 
accessing and completing the survey. 
 
Data Analysis  
Descriptive statistics were computed to summarize survey 
responses.  For potential reasons for joining/not joining the 
PBRN, we also compared pharmacist ratings versus support 
staff, individuals with research experience versus without, 
differences by type, location, and prescription volume of 
pharmacy, and differences by level of current interest in the 
PBRN.   For the ratings of potential research topics, we 
compared pharmacists versus support staff and differences 
by type and location of pharmacy, and by level of current 
interest in the PBRN.  Finally, we compared respondent 
overall interest level in the PBRN by sex, age, pharmacists 
versus support staff, pharmacy location, type, and 
prescription volume, whether the individual has past research 
experience, and by whether the pharmacist has additional 
certifications or offers additional patient care services.  
Comparisons were made using nonparametric or parametric 
tests, as appropriate.  Pertinent findings are presented below. 
 
A p-value of < 0.05 was considered statistically significant for 
all omnibus analyses.  When appropriate, follow-up pairwise 
comparisons were made, and a p-value of < 0.01 was 
considered statistically significant for post-hoc analyses. 
 
Results 
Sample 
The online survey was accessed 187 times, and useable data 
were acquired from 180 respondents.  One hundred forty 
pharmacists completed the survey (Table 1), along with 40 
support staff (Table 2).  The number of unique pharmacies 
represented by survey respondents is unknown.   
 
Respondents represented 53 of the 92 Indiana counties 
(n=178 responses to this question).  Survey responses were 
evenly distributed between community pharmacy types (i.e., 
chain, independent, etc.).  Most pharmacist respondents 
were either pharmacy managers and/or owners, and the 
majority of non-pharmacist respondents were technicians.  
Among pharmacist respondents, few possessed advanced 
degrees or certifications with the exception of immunization 
certification.  The provision of patient care services was more 
common and primarily included medication therapy 
management (i.e., service in which a patient’s medication 
regimen is reviewed by a pharmacist), immunizations, and 
services to long-term care facilities. 
 
Anticipated Barriers to Participation in the PBRN 
Rated on a scale from 1 to 10 (1= not at all important to 10= 
very important), time constraints (median rating= 8), lack of 
research experience (median rating= 6), and difficulty 
recruiting patients (median rating= 6) were the highest rated 
perceived barriers, overall; 59.1% chose “time constraints” as 
the most important reason to not participate.  Comparing the 
importance of barriers between groups of respondents (Table 
3) revealed that pharmacists considered time constraints a 
more important barrier than did support staff.  Across PBRN 
interest levels, we found significant differences in ratings of 
time constraints, lack of research experience, community 
distrust of research, and staff turnover.  Pair-wise 
comparisons, significant at p < 0.01, found that individuals 
very interested in the PBRN rated time constraints, lack of 
research experience, and staff turnover lower than did those 
who were not interested.  Across pharmacy types, the only 
difference in reasons for not participating was perceived 
unwillingness of employer to participate (p= 0.009); pair-wise 
comparisons demonstrated that respondents from 
independent pharmacies rated this barrier lower than did 
respondents from chain pharmacies (median ratings of 4 vs 
6.5, p= 0.008) and mass merchandiser/grocery pharmacies 
(median ratings 4 vs 7, p=0.002).  We found no differences in 
ratings of barriers by pharmacy location or prescription 
volume. 
 
Anticipated Facilitators to Participation in the PBRN 
Enrichment of patient care, improved relationships with 
patients/providers, and greater medication safety knowledge 
were the highest-rated potential reasons for participating 
(Table 3); overall, 40.1% of respondents indicated that 
“enrichment of patient care” was the most important reason 
for PBRN participation. 
 
Support staff rated the potential for monetary compensation 
and greater medication safety knowledge higher than did 
pharmacists.  In general, pair-wise comparisons found that 
the potential for improved job satisfaction, opportunities for 
professional development, networking opportunities, 
enrichment of patient care, and enhanced relationship with 
the College of Pharmacy were rated higher by individuals 
expressing a greater interest in the PBRN (p-values < 0.01).  
Furthermore, there were no differences in ratings of 
facilitators across pharmacy type, location, prescription 
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volume, or whether respondents reported experience with 
research in the past. 
Examples of additional reasons to participate that were 
written in by respondents included addressing narcotics and 
controlled medication issues, enhancing compliance and 
understanding in patients, and “increasing business 
opportunities by filling unmet needs.” 
 
Respondent Interest in PBRN Participation 
More than one-third of respondents (n=64, 38.3%) indicated 
that they would need more information to decide how 
interested they were in PBRN participation; 57 respondents 
(34.1%) were somewhat interested, 25 (15%) were very 
interested, and 21 (12.6%) were not interested.  Support staff 
were more likely than pharmacists to want additional 
information before deciding how interested they are in the 
network (59% of support staff wanted more information vs. 
32% of pharmacists, p=0.017). 
 
Potential PBRN Research Topics 
Respondents’ ratings of perceived importance for potential 
PBRN research topics (focused on issues related to 
medication safety) are shown in Table 4.  All research topics 
provided were rated as important (i.e. a median rating of 8 or 
above) however, dispensing errors were rated as the most 
important area of study.  The only rating difference among 
groups was for the rating of medication reconciliation by 
PBRN interest level (p= 0.045).  Pair-wise comparisons 
indicated that respondents who were very interested in the 
PBRN rated the importance of medication reconciliation 
higher than did those not interested.  The top three topics 
selected by respondents as being the most interesting 
projects to be involved with were dispensing errors (27.7%), 
health information technology (24.1%), and patient 
education/medication therapy management (20.5%). 
 
Discussion 
Most respondents were either somewhat interested in 
joining the PBRN or wanted more information, with 
pharmacists tending to be more interested than support staff 
in joining the network.  An overall high level of interest was 
not unexpected and may indicate a degree of response bias 
as those at least somewhat interested in research and/or 
PBRNs were probably more likely to participate in the survey.  
Our findings highlighted an overall lack of research 
experience and exposure to PBRNs by respondents.  In order 
to address the need to better inform our potential members 
about PBRNs, Rx-SafeNet leadership initially held two 
webinars along with four live information sessions in cities 
throughout Indiana after the completion of the survey.  As 
part of these outreach sessions, “FAQs” were presented, 
using survey findings to assist in preparing responses.  
Because Rx-SafeNet’s membership is at the pharmacy level 
(as opposed to recruiting individual practitioners), it is 
important to educate and involve all pharmacy staff members 
in ongoing educational activities.  To date, our information 
sessions have primarily reached pharmacists, but, considering 
the results of this survey, Rx-SafeNet plans to pursue 
educational/outreach venues specific to support staff as 
more pharmacies enter the network.  This is especially 
important as we found that support staff were more hesitant 
to express interest in network participation without more 
information. 
 
Limited past research experience of survey respondents 
points to a need for attention to the development of solid 
training programs.  Sufficient training will help our 
membership receive the greatest benefit from participating in 
the network and aligns with recommendations from the 
literature.
5
  Rx-SafeNet recently completed data collection for 
its first research project which, in terms of exploring network 
procedures, is thought of as a pilot, with participation of a 
single pharmacy.  The staff at the pharmacy involved received 
research training in the form of online Collaborative 
Institutional Training Initiative (CITI) modules (as required 
based on specific study activities), as well as on-site training 
by Rx-SafeNet leadership.  Project site employees will 
continue to be trained using these methods, but future 
implementation of a standard research training program may 
be useful (and is under development) to complement these 
efforts, similar to the one developed by the American 
Academy of Family Physicians National Research Network.
6
  
Respondents rated every proposed research topic as 
important, suggesting they value medication safety research.  
This indirectly shows support for the mission of Rx-SafeNet.  
The project interests of actual network members will partially 
be discerned through our approach to project selection; 
pharmacies are contacted with project ideas submitted to 
network leadership and only those ideas with sufficient 
interest from members are pursued.  Although “dispensing 
errors” received the highest overall rating, it is not yet known 
to what extent this topic will be pursued as, to date, only one 
related project idea has been submitted.  We may see greater 
emphasis on this topic as we have more project ideas 
submitted from member pharmacies, instead of students, 
faculty, and/or residents and outside investigators.  (The 
originators of the ideas submitted to date.) 
 
Having a clear understanding of what potential members of 
Rx-SafeNet consider to be the greatest participation 
facilitators and barriers provided a strong foundation for 
development of network policies and procedures that 
highlight and diminish those features respectively.  As would 
be expected, individuals who were very interested in the 
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PBRN generally rated participation facilitators higher and 
barriers lower than those less interested.  The highest rated 
reasons to participate included the potential for improved 
relationships with patients and other providers, enrichment 
of patient care, and greater knowledge of medication safety 
practices.  The importance clinicians placed on engaging in 
research that enhances knowledge and improves care closely 
aligns with the results of similar surveys,
3,8,11
 and the 
discussion by Mold and Peterson regarding the integration of 
quality improvement and research efforts in PBRN efforts
12
 
and should be on the foremost thoughts of all PBRNs.  The 
commitment of network members to improving patient care 
will aid in our ability to translate what is discovered from 
research into practice. 
 
Time constraints (even if provided compensation) were 
shown to be one of the largest perceived barriers to 
participation.  This highlights the competing demands for 
practitioners’ time in community pharmacies and has been 
cited as a barrier to PBRN participation previously.
3,11, 13-14
  
Therefore, Rx-SafeNet would be remiss not to alleviate the 
time pressures of conducting research by integrating it well 
into daily tasks.  Every project is reviewed by a Project Review 
Team, currently comprised of College of Pharmacy faculty, so 
that protocols will be designed to accomplish this goal.  
Similar review panels are employed by other networks.
15,16
  In 
its first project, Rx-SafeNet employed additional creative 
measures to facilitate project implementation into the unique 
work environment of community pharmacy..  The limited 
concern over staff turnover was somewhat surprising, and in 
contrast to other studies,
4
 but bodes well for the network if 
members have a stable workforce. 
 
Limitations 
The majority of respondents were pharmacy managers and 
owners.  We had a low response overall, although we are 
unable to calculate a true response rate without knowledge 
of the denominator (i.e. the total number of employees 
exposed to the survey).  However, the goal of this work was 
to gather opinions relevant to the formation of the new 
PBRN.  Therefore, although interest can’t be extrapolated to 
all Indiana community pharmacy employees, we feel 
responses were still useful in predicting the needs and desires 
of future members as they were probably more likely to 
respond. Additionally, limitations exist around using a web-
based format for the survey as some pharmacies may only 
have limited internet access, thereby requiring study 
participants to access the survey elsewhere.  This could have 
impacted our response.  
 
 
 
Conclusion 
Founders of the Medication Safety Research Network of 
Indiana administered a survey to community pharmacy 
employees prior to network launch to assess research 
interests and barriers/facilitators to joining a PBRN.  This 
survey, as one step in a multi-faceted approach to network 
establishment, has served as one of the cornerstones that 
network leadership believe will aid in the longevity and 
productivity of the network.  While there are limitations to 
the generalizability of our results, individuals developing 
community pharmacy PBRNs, and other networks that 
involve both clinicians and non-clinicians, may benefit from 
considering this survey approach early in network formation. 
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Table 1.  Characteristics of Pharmacist Respondents* 
 
Characteristic Results 
Male sex, n (%) 66 (51.6) 
Age, mean (range) 44.9 (24-73) 
Years as RPh, mean (range) 20.8 (0-49) 
Pharmacy degree received, n (%) 
      
 
B.S. 
PharmD 
B.S. and PharmD 
94 (72.9) 
33 (25.6) 
2 (1.6) 
Type of pharmacy where employed, n (%) 
      
 
Independent retail/community 
Chain retail/community 
Mass merchant or grocery store retail/community 
Hospital/health-system outpatient pharmacy 
Other 
41 (29.3) 
38 (27.1) 
41 (29.3) 
12 (8.6) 
8 (5.7) 
Position within pharmacy, n (%) Pharmacist manager and/or owner 
Full-time staff pharmacist 
Part-time staff pharmacist 
Floater/temporary staff pharmacist 
118 (84.3) 
18 (12.9) 
4 (2.9) 
0 (0) 
Location of pharmacy where employed, n (%) 
 
Urban/inner city (> 50,000 people) 
City (10,000-50,000 people) 
Town (< 10,000 people) 
44 (31.4) 
61 (43.6) 
35 (25) 
Approximate # of prescriptions filled per week, n (%) 
 
 < 1000 
1000-2500 
 > 2500 
66 (47.5) 
64 (46) 
9 (6.5) 
Completed residency, n (%) 
 
PGY-1 
PGY-2 
Both PGY-1 and PGY-2 
2 (1.6) 
0 (0) 
0 (0) 
Additional certifications obtained, n (%) 
      
 
Board Certified Pharmacotherapy Specialist (BCPS) 
APhA Immunization Certificate Program 
Certified Diabetes Educator (CDE) 
APhA Lipids Management Certificate Program 
APhA Medication Therapy Management Certificate Program 
Certified Geriatrics Pharmacist (CGP) 
Other 
0 (0) 
49 (38.6) 
4 (3.1) 
6 (4.7) 
3 (2.4) 
2 (1.6) 
11 (8.7) 
Additional services offered at pharmacy, n (%) 
 
Medication Therapy Management 
Immunizations 
Long-term Care consulting or prescriptions 
Disease State Management 
Other 
43 (34.1) 
56 (44.4) 
17 (13.5) 
10 (7.9) 
8 (6.3) 
Completion of formal research training program, n 
(%) 
 
Research Fellowship 
M.S. with focus in research 
Doctorate with focus in research 
0 (0) 
1 (0.7) 
2 (1.4) 
Completion of working with human subjects 
certification program, n (%) 
 
Yes 
No 
Doesn’t know 
3 (2.1) 
134 (95.7) 
3 (2.1) 
Experience with research activities, n (%) 
      
 
Serving as Principal Investigator/Project Leader 
Collecting data 
Analyzing data 
Writing up research results 
7 (5) 
33 (23.7) 
20 (14.4) 
18 (12.9) 
Past experience with PBRNs, n (%) 
      
 
Current member 
Not current member but member of PBRN in the past 
Never a member of a PBRN 
0 (0) 
2 (1.4) 
138 (98.6) 
*Total n= 140, some respondents did not answer every question. 
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Table 2.  Characteristics of Support Staff Respondents* 
 
Characteristic Results 
Male sex, n (%) 8 (21.1) 
Age, mean (range) 37.4 (20-63) 
Highest education received, n (%) 
      
 
High school diploma/GED 
Some college 
2-Year college degree (Associates) 
4-Year college degree (Bachelors) 
Other 
9 (23.7) 
15 (39.5) 
4 (10.5) 
4 (10.5) 
6 (15.8) 
Type of pharmacy where employed, n 
(%) 
 
Independent retail/community 
Chain retail/community 
Mass merchant or grocery store retail/community 
Hospital/health-system outpatient pharmacy 
Other 
13 (32.5) 
17 (42.5) 
5 (12.5) 
0 (0) 
5 (12.5) 
Position within pharmacy, n (%) 
 
Pharmacy technician 
Pharmacy clerk 
Student pharmacy intern 
Other (compounding technician) 
33 (82.5) 
2 (5) 
4 (10) 
1 (2.5) 
Location of pharmacy where 
employed, n (%) 
      
Town (< 10,000 people) 
City (10,000-50,000 people) 
Urban/inner City (> 50,000 people) 
3 (7.5) 
28 (70) 
9 (22.5) 
Completion of formal research 
training program, n (%) 
Research fellowship 
M.S. with focus in research 
Doctorate with focus in research 
0 (0) 
0 (0) 
0 (0) 
Completion of working with human 
subjects certification program, n (%) 
      
Yes 
No 
Doesn’t know 
1 (2.5) 
38 (95) 
1 (2.5) 
Experience with research activities, n 
(%) 
      
 
Serving as Principal Investigator/Project Leader 
Collecting data 
Analyzing data 
Writing up research results 
1 (2.6) 
5 (12.8) 
5 (12.8) 
6 (15.4) 
Past experience with PBRNs, n (%) 
      
 
Current member 
Not current member but member of PBRN in the past 
Never a member of a PBRN 
0 (0) 
0 (0) 
40 (100) 
*Total n= 40, some respondents did not answer every question. 
 
  
Original Research PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                       2012, Vol. 3, No. 2, Article 79                           INNOVATIONS in pharmacy   9 
 
Table 3. Respondent Ratings (Median, Interquartile Range)  
of Reasons to Participate or Not Participate, by Position in Pharmacy and Interest in PBRN 
 
 Position in Pharmacy Level of Interest* 
Potential Reasons to Participate, Median (Interquartile range)† 
Pharmacist 
n= 140‡ 
Support Staff 
n= 40‡  
p-value V SW Not NMI p-value 
Enhanced Job Satisfaction 
Opportunities for professional development 
Enhancement of the pharmacy’s “image” 
Monetary compensation 
Opportunity to network with peers 
Improved relationships with patients and other health care providers 
Enrichment of patient care 
Enhanced relationship with Purdue College of Pharmacy 
Greater knowledge of medication safety practices 
Opportunity for continuing education credit 
8 (6-9) 
6 (4-8) 
8 (6-9) 
6 (4-7.75) 
7 (5-8) 
9 (7-9) 
9 (8-10) 
7 (5-8.5) 
9 (7-10) 
8 (6-9) 
7.5 (5.75-10) 
6 (4.75-8) 
8 (6-10) 
7 (5-9) 
6.5 (5-9) 
9 (8-10) 
9 (8-10) 
6.5 (3.75-8) 
9.5 (7.75-10) 
8 (6-10) 
0.876 
0.838 
0.835 
0.021 
0.873 
0.200 
0.612 
0.569 
0.047 
0.639 
9 (8-9) 
9 (6-9.5) 
9 (7-10) 
6 (5-8) 
8 (7-9) 
9 (8-10) 
10 (9-10) 
9 (7-9) 
9 (8-10) 
8 (7-9) 
8 (6-10) 
6 (3-8) 
8 (6-9) 
5 (3-7) 
7 (5-8) 
9 (8-9) 
9 (8-10) 
7 (5-8) 
9 (7-10) 
7 (6-9) 
5 (4-7.75) 
5 (2-5) 
6 (4.5-9) 
5 (3-7) 
5 (3-6.75) 
7 (5.25-9) 
8 (7-10) 
5 (2-6) 
8 (6-9) 
6 (5-8.75) 
7 (6-9) 
6 (5-8) 
8 (7-10) 
6 (5-8) 
7 (6-9) 
9 (8-10) 
9 (8-10) 
6 (4-8) 
9 (7-10) 
8 (6-10) 
0.001 
< 0.001 
0.092 
0.047 
< 0.001 
0.036 
0.032 
< 0.001 
0.235 
0.092 
Potential Reasons to Not Participate, Median (Interquartile range)         
Time constraints (even if provided with compensation) 
Lack of personal experience doing research 
Employer unwillingness to participate 
Difficulty in recruiting patient participation 
High percentage of patients that speak English as second language 
Community distrust of research 
Staff Turnover 
8 (6-9.5) 
6 (4-8) 
5 (2-8) 
7 (5-8) 
2 (1-5) 
3 (1-5) 
2 (1-5) 
7 (5-8) 
6 (3-9) 
5 (3-7.75) 
6 (4-7) 
4 (1-7) 
3.5 (1-6) 
3 (1-5) 
<0.001 
0.896 
0.781 
0.058 
0.095 
0.537 
0.670 
6 (3.5-8) 
3.5 (2-6) 
3.5 (1-6) 
5 (3.5-7.5) 
1 (1-4) 
1 (1-3) 
1 (1-2) 
8 (5.25-9) 
6 (4.75-8) 
5.5 (2-8) 
7 (4-8) 
2 (1-5) 
3 (1.75-6) 
3 (1-5) 
8 (7.5-10) 
8.5 (6.25-10) 
7 (5-9) 
7 (5.25-8.75) 
2 (1-5) 
3.5 (1-6.25) 
3 (1-6.5) 
8 (7-9) 
7 (4-9) 
5.5 (3-8) 
6 (5-8) 
3 (1-6) 
3.5 (1-6) 
3 (1-5) 
0.014 
<0.001 
0.062 
0.274 
0.176 
0.009 
0.009 
*V= Very Interested; SW= Somewhat Interested; Not= Not Interested; NMI= Needs additional information to determine level of interest 
†Rated on scale of 1= Not at all important to 10= Very important 
 
 
 
 
 
 
Table 4. Respondent Ratings (Median, Interquartile Range) of the Importance of Selected Medication Safety Research Areas* 
 
Research Topic, median (interquartile range) Results
† 
Dispensing errors 
Relationship between health information technology and medication safety 
Medication reconciliation 
Medical literacy and medication safety 
Patient education/medication therapy management and adverse drug events 
Economic impact of medication safety effort 
10 (9-10) 
9 (8-10) 
9 (8-10) 
9 (7.25-10) 
8 (7-10) 
8 (6-10) 
*Total n= 180, some respondents did not answer every question 
†Rated on scale of 1= Not at all important to 10= Very important 
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Appendix 1. Pharmacist Survey Questions 
 
The first few questions will help us to learn a little about the pharmacy where you work. 
1. How would you describe the pharmacy where you work? 
a. Independent Retail/Community Pharmacy   
b. Chain Retail/Community Pharmacy (e.g., Walgreens, CVS, Rite Aid, etc)  
c. Mass merchant or Grocery Store Pharmacy (e.g., Target, Wal-Mart, Costco, Marsh, Kroger, etc) 
d. Outpatient Pharmacy owned or managed by Hospital/Health-System (e.g., Clarian Health Prescription Centers ) 
e. Other______________________________ 
 
2. What is your position in the Pharmacy? 
a. Pharmacist  
b. Not a pharmacist  
 
3. Which of the following best describes your position in the pharmacy? 
a. Staff Pharmacist (floater and/or temporary) 
b. Staff Pharmacist (part-time) 
c. Staff Pharmacist (full-time) 
d. Pharmacist Manager and/or Owner 
 
4. What is the location of your pharmacy? 
a. Town (less than 10,000 people)  
b. City (between 10,000 and 50,000) 
c. Urban/Inner City (> 50,000 people) 
 
5. What Indiana county is your pharmacy located in? 
 
6. Approximately how many prescriptions are dispensed at your pharmacy per week? 
a. < 1000 
b. 1000-2500 
c. >2500 
 
The next group of questions will help us to learn more about your past experiences with research. 
7. Have you completed any formal research training program?  Please mark all that you have completed. 
a. A Research Fellowship 
b. A Master’s Degree with a focus in research 
c. A Doctoral Degree with a focus in research 
d. I have not completed a formal research training program. 
 
8. Have you completed a certification program that enables you to conduct research involving human subjects?   
a. Yes 
b. No 
c. I don’t know 
 
9. Which of the following research activities do you have experience with? Please mark all that apply. 
a. Serving as the project leader/principal investigator 
b. Collecting data for a research project (includes administering surveys, reviewing patient records, etc.) 
c. Analyzing research data 
d. Writing up the results of a research project 
e. I do not have experience with any of the above activities. 
 
10. Are you currently a member of a practice-based research network (PBRN)? 
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a. Yes, I am currently a member  
i. What PBRN are you a member of? _______________ 
b. No, but I was a member of a PBRN in the past  
i. What PBRN did you belong to? ________________ 
c. No, I have never been a member of a PBRN 
 
The next group of questions will help us to know your opinions and ideas about the practice-based research network (PBRN) 
being developed here in Indiana. 
11. Please indicate how important you feel each of the following medication safety topics are as potential issues for the PBRN 
to study.  1= Not at all important to 10= very important. 
a. The relationship between health information technology (e.g., e-prescribing, electronic health records, etc.) and 
medication safety  
b. Patient medical literacy (e.g. the ability to read, comprehend and then apply medical information) as related to 
medication safety  
c. Medication Reconciliation (i.e., assessing the agreement between medications prescribed and those being used by 
the patient.)  
d. Minimizing dispensing errors  
e. Patient education and Medication Therapy Management (MTM) as a mechanism for preventing, detecting and 
managing adverse drug events (ADEs) 
f. The economic impact of medication safety efforts   
 
12. Are there any additional important medication safety topics not included above? 
a. Additional topics include: ______________ 
b. I can think of no additional topics. 
 
13. Please select the topic that would the most interesting to you as a research project to get involved in.  
a. The relationship between health information technology (e.g., e-prescribing, electronic health records, etc.) and 
medication safety  
b. Patient medical literacy (i.e., the ability to read, comprehend and then apply medical information) as related to 
medication safety  
c. Medication Reconciliation (i.e., assessing the agreement between medications prescribed and those being used by 
the patient.) 
d. Minimizing dispensing errors  
e. Patient education and Medication Therapy Management (MTM) as a mechanism for preventing, detecting and 
managing adverse drug events (ADEs) 
f. The economic impact of medication safety efforts   
g. Other _____________________________________________________________ 
 
14. Please rate the importance of each of the following as reasons for participating in the new Indiana community pharmacy 
PBRN.  1= Not at all important to 10= very important. 
a. Enhanced job satisfaction 
b. Opportunities for professional development (e.g. the chance to conduct and publish research) 
c. Enhancement of the overall “image” of the pharmacy 
d. Monetary compensation provided to the pharmacy for participating in research efforts 
e. Opportunity to network with peers from other community pharmacies 
f. Improved relationship with patients and other health care providers in your community 
g. Enrichment of care provided to patients 
h. Enhanced relationship with Purdue University School of Pharmacy and Pharmaceutical Sciences  
i. Greater knowledge of medication safety practices 
j.  Opportunity for continuing education credit  
k.  
15. Are there any additional important reasons for participating that were not included above?  
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a. Additional reasons include: _________________ 
b. I can think of no additional reasons. 
 
16. Which of the following would you view as the most important reason for participating in the new Indiana community 
pharmacy PBRN?   
a. Enhanced job satisfaction 
b. Opportunities for professional development (e.g. the chance to conduct and publish research) 
c. Enhancement of the overall “image” of the pharmacy 
d. Monetary compensation provided to the pharmacy for participating in research efforts 
e. Opportunity to network with peers from other community pharmacies 
f. Improved relationship with patients and other health care providers in your community 
g. Enrichment of care provided to patients 
h. Enhanced relationship with Purdue University School of Pharmacy and Pharmaceutical Sciences  
i. Greater knowledge of medication safety practices 
j.  Opportunity for continuing education credit  
k. Other________ 
 
17. Please rate the importance of each of the following as reasons for NOT participating in the new Indiana community 
pharmacy PBRN.  1= Not at all important to 10= very important. 
a. Time constraints (even if provided with compensation) 
b. Lack of personal experience doing research  
c. Employer unwillingness to participate 
d. Difficulty in recruiting patient participation  
e. High percentage of patients that speak English as a second language  
f. Community distrust of research  
g. Staff turnover  
 
18. Are there any additional important reasons for NOT participating that were not included above?   
a. Additional reasons include: ________________ 
b. I can think of no additional reasons. 
 
19. Which of the following would you view as the most important reason for NOT participating in the new Indiana community 
pharmacy PBRN?   
a. Time constraints (even if provided with compensation) 
b. Lack of personal experience doing research  
c. Employer unwillingness to participate 
d. Difficulty in recruiting patient participation  
e. High percentage of patients that speak English as a second language  
f. Community distrust of research  
g. Staff turnover  
h. Other____________ 
 
20. How would you describe your interest in participating in a state-wide community pharmacy PBRN? 
a. I am very interested in participating in the community pharmacy practice-based research network. 
b. I am somewhat interested in participating in the community pharmacy practice-based research network. 
c. I am not interested in participating in the community pharmacy practice-based research network. 
d. I would need more information in order to decide how interested I am in participating in the community pharmacy 
practice-based research network. 
 
 
 
Finally, the last few questions will gather some basic background information. 
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21. What is your sex?  
a. Male 
b. Female 
 
22. What is your age?  
a. __________ 
 
23. How many years have you been a registered pharmacist? 
a. __________ 
 
24. Which pharmacy degree did you receive? 
a. Bachelors Degree in pharmacy (B.S.) 
b. Doctor of Pharmacy (Pharm.D) 
c. Both a Bachelors Degree in Pharmacy and a Pharm.D 
 
25. Have you completed a residency program?  Please check all that you have completed. 
a. Post-graduate Year 1 (PGY-1) Residency 
b. Post-graduate Year 2 (PGY-2) Residency 
c. Both a PGY-1 and PGY-2 Residency 
d. I have not completed a residency program. 
 
26. What further certifications do you possess? Check all that apply. 
a. Pharmacotherapy specialist (BCPS) 
b. Immunization delivery (APhA certificate program) 
c. Diabetes Educator(CDE) 
d. Lipids Management (APhA certificate program) 
e. Medication Therapy Management (APhA certificate program) 
f. Geriatrics Pharmacist (CGP) 
g. Other _____________________________________________ 
h.  None 
 
27. What additional services do you offer? Please check all that apply. 
a. Medication Therapy Management (by appointment, can be either for Medicare Part D or non-Medicare patients) 
b. Immunizations  
c. Consultant and/or prescription services for nursing homes or long-term care facilities 
d. Disease state management (e.g. Diabetes or Anticoagulation Clinic) 
e. Other ______________________________________________ 
f. None 
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Appendix 2. Support Staff Survey Questions 
 
The first few questions will help us to learn a little about the pharmacy where you work. 
 
1. How would you describe the pharmacy where you work? 
a. Independent Retail/Community Pharmacy   
b. Chain Retail/Community Pharmacy (e.g., Walgreens, CVS, Rite Aid, etc)  
c. Mass merchant or Grocery Store Pharmacy (e.g., Target, Wal-Mart, Costco, Marsh, Kroger, etc) 
d. Outpatient Pharmacy owned or managed by Hospital/Health-System (e.g., Clarian Health Prescription Centers ) 
e. Other______________________________ 
 
2. What is your position in the Pharmacy? 
a. Pharmacist  
b. Not a pharmacist  
 
3. Which of the following best describes your position in the pharmacy? 
a. Pharmacy Technician 
b. Pharmacy Clerk 
c. Student Pharmacy Intern  
d. Other_________ 
 
4. What is the location of your pharmacy? 
a. Town (less than 10,000 people)  
b. City (between 10,000 and 50,000) 
c. Urban/Inner City (> 50,000 people) 
 
5. What Indiana county is your pharmacy located in? 
 
The next group of questions will help us to learn more about your past experiences with research. 
 
6. Have you completed any formal research training program?  Please mark all that you have completed. 
a. A Research Fellowship 
b. A Master’s Degree with a focus in research 
c. A Doctoral Degree with a focus in research 
d. I have not completed a formal research training program. 
 
7. Have you completed a certification program that enables you to conduct research involving human subjects?   
a. Yes 
b. No 
c. I don’t know 
 
8. Which of the following research activities do you have experience with? Please mark all that apply. 
a. Serving as the project leader/principal investigator 
b. Collecting data for a research project (includes administering surveys, reviewing patient records, etc.) 
c. Analyzing research data 
d. Writing up the results of a research project 
e. I do not have experience with any of the above activities. 
 
9. Are you currently a member of a practice-based research network (PBRN)? 
a. Yes, I am currently a member  
i. What PBRN are you a member of? _______________ 
b. No, but I was a member of a PBRN in the past  
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i. What PBRN did you belong to? ________________ 
c. No, I have never been a member of a PBRN 
 
The next group of questions will help us to know your opinions and ideas about the practice-based research network (PBRN) 
being developed here in Indiana. 
 
10. Please indicate how important you feel each of the following medication safety topics are as potential issues for the PBRN 
to study.  1= Not at all important to 10= very important. 
a. The relationship between health information technology (e.g., e-prescribing, electronic health records, etc.) and 
medication safety  
b. Patient medical literacy (i.e.,  the ability to read, comprehend and then apply medical information) as related to 
medication safety  
c. Medication Reconciliation (i.e., assessing the agreement between medications prescribed and those being used by 
the patient.) 
d. Minimizing dispensing errors  
e. Patient education and Medication Therapy Management (MTM) as a mechanism for preventing, detecting and 
managing adverse drug events (ADEs) 
f. The economic impact of medication safety efforts   
 
11. Are there any additional important medication safety topics not included above? 
a. Additional topics include: ______________ 
b. I can think of no additional topics. 
 
12. Please select the topic that would the most interesting to you as a research project to get involved in.  
a. The relationship between health information technology (e.g., e-prescribing, electronic health records, etc.) and 
medication safety  
b. Patient medical literacy (e.g. the ability to read, comprehend and then apply medical information) as related to 
medication safety  
c. Medication Reconciliation (i.e., assessing the agreement between medications prescribed and those being used by 
the patient.) 
d. Minimizing dispensing errors  
e. Patient education and Medication Therapy Management (MTM) as a mechanism for preventing, detecting and 
managing adverse drug events (ADEs) 
f. The economic impact of medication safety efforts   
g. Other _____________________________________________________________ 
 
13. Please rate the importance of each of the following as reasons for participating in the new Indiana community pharmacy 
PBRN.  1= Not at all important to 10= very important. 
a. Enhanced job satisfaction 
b. Opportunities for professional development (e.g. the chance to conduct and publish research) 
c. Enhancement of the overall “image” of the pharmacy 
d. Monetary compensation provided to the pharmacy for participating in research efforts 
e. Opportunity to network with peers from other community pharmacies 
f. Improved relationship with patients and other health care providers in your community 
g. Enrichment of care provided to patients 
h. Enhanced relationship with Purdue University School of Pharmacy and Pharmaceutical Sciences  
i. Greater knowledge of medication safety practices 
j.  Opportunity for continuing education credit  
 
14. Are there any additional important reasons for participating that were not included above (question 13)?  
a. _________________________________________________________________ 
b. I can think of no additional reasons. 
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15. Which of the following would you view as the most important reason for participating in the new Indiana community 
pharmacy PBRN?   
a. Enhanced job satisfaction 
b. Opportunities for professional development (e.g. the chance to conduct and publish research) 
c. Enhancement of the overall “image” of the pharmacy 
d. Monetary compensation provided to the pharmacy for participating in research efforts 
e. Opportunity to network with peers from other community pharmacies 
f. Improved relationship with patients and other health care providers in your community 
g. Enrichment of care provided to patients 
h. Enhanced relationship with Purdue University School of Pharmacy and Pharmaceutical Sciences  
i. Greater knowledge of medication safety practices 
j.  Opportunity for continuing education credit  
k. Other_______________ 
 
16. Please rate the importance of each of the following as reasons for NOT participating in the new Indiana community 
pharmacy PBRN.  1= Not at all important to 10= very important. 
a. Time constraints (even if provided with compensation) 
b. Lack of personal experience doing research  
c. Employer unwillingness to participate 
d. Difficulty in recruiting patient participation  
e. High percentage of patients that speak English as a second language  
f. Community distrust of research  
g. Staff turnover  
 
17. Are there any additional important reasons for NOT participating that were not included above (question 15)?  
a. _________________________________________________________________ 
b. I can think of no additional reasons. 
 
18. Which of the following would you view as the most important reason for NOT participating in the new Indiana community 
pharmacy PBRN?   
a. Time constraints (even if provided with compensation) 
b. Lack of personal experience doing research  
c. Employer unwillingness to participate 
d. Difficulty in recruiting patient participation  
e. High percentage of patients that speak English as a second language  
f. Community distrust of research  
g. Staff turnover  
h. Other_________ 
 
19. How would you describe your interest in participating in a state-wide community pharmacy PBRN? 
a. I am very interested in participating in the community pharmacy practice-based research network. 
b. I am somewhat interested in participating in the community pharmacy practice-based research network. 
c. I am not interested in participating in the community pharmacy practice-based research network. 
d. I would need more information in order to decide how interested I am in participating in the community pharmacy 
practice-based research network. 
 
Finally, the last few questions will gather some basic background information. 
20. What is your sex?  
a. Male 
b. Female 
 
Original Research PRACTICE-BASED RESEARCH 
 
http://z.umn.edu/INNOVATIONS                       2012, Vol. 3, No. 2, Article 79                           INNOVATIONS in pharmacy   17 
 
21. What is your age?  
a. __________ 
 
22. What is the greatest level of education you have received? 
a. High School Diploma/GED 
b. Some college 
c. 2 year college degree (Associates) 
d. 4 year college degree (BA, BS) 
e. Other __________ ____________ 
 
 
 
